Chai Discovery AI antibody design collaboration
Disclosed: Verified: Partners: Chai Discovery
Chai Discovery announced a collaboration agreement giving argenx access to its AI platform to apply de novo antibody discovery across therapeutic targets.
Source
Vendor Archive pending